fashion -WSS

fashion

author：focus 2025-09-27 22:59:35 - browse：5

Adobe

Over the last few years, virtual mental health company Talkspace has been on a relentless quest to conquer the insurance market. The next step in that journey, Medicare, may prove the most challenging yet.

Talkspace’s pivot away from its direct-to-consumer roots has so far been a success. The company claims 130 million people have access to its services through deals with insurers, employers, or through other arrangements, and it is now knocking on the door of profitability — an impressive feat for any digital health company. CEO Jon Cohen told STAT the expansion to Medicare, which it announced earlier this year, is a natural evolution of its strategy of becoming a comprehensive in-network teletherapy provider for as many people as possible.

If Talkspace can convince people on Medicare to flock to its services, it will further cement the company’s status as one of the strongest virtual care businesses to emerge from the post-pandemic health tech boom. And, the ability to serve adults 65 and older could prove an important distinction in the eyes of investors and potential strategic partners in the health care industry.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： HCA sued by state AG for quality issues at Mission Health

hotspot

leisure time

WSS

California wildfire smoke linked to 52,000 early deaths, study says

Can sheer will power keep patients alive in their dying hours?

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Christmas in the PICU brings some surprising joy

CRISPR gene editing developments we’re watching in 2024

Coercive sterilizations revealed by STAT prompt outrage

hotspot

fashion

explore

Activists slam private health insurers over coverage restrictions

Why health care costs have stayed mostly flat since 2010

Medical records are filled with copy

Bristol Myers buys into radiopharmaceuticals with RayzeBio

The cancer drug shortage isn’t new — and neither are the solutions

Medical device trials still don't enroll enough women, study finds

Alkermes shareholders re

Cheap, fast test for Zika and dengue could cost just $1

New air purifier tech could be key to improving indoor air quality

Albert Bourla of Pfizer: worst biopharma CEO of 2023

entertainment

What STAT readers think about the FDA and patient advocacy

Medical device trials still don't enroll enough women, study finds

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Bristol Myers buys into radiopharmaceuticals with RayzeBio

ALS patient reclaims some autonomy thanks to wearable 'robot'

Deposition: Sackler embraced plan to conceal OxyContin’s strength

entertainment

hotspot

leisure time

leisure time